Glycomet GP 3/850 mg Tablet (10 Tab)

About Glycomet GP 3/850 mg Tablet:

Glycomet GP 3/850 mg tablet is a combination of two anti-diabetic medications, used to treat type 2 diabetes mellitus.

Each uncoated Glycomet GP 3/850 mg tablet contains Metformin Hydrochloride 850 mg as sustained release form and Glimepiride 3 mg.

Glimepiride, an anti-diabetic sulphonylurea, reduces blood glucose by stimulating the insulin release from pancreatic ß-cells and decreases glucose output from the liver. It also increases insulin sensitivity at peripheral target sites.

Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.

Use of Glycomet GP 3/850 mg Tablet:

Glycomet GP 3/850 mg tablet is prescribed for the treatment of type 2 diabetes mellitus.

Usage direction of Glycomet GP 3/850 mg Tablet:

• Glycomet GP 3/850 mg tablet should be taken orally.
• Glycomet GP 3/850 mg tablet is taken whole with the help of water.
• Do not crush, chew, or break the tablet.
• Do not skip or stop the medicine without physician's advice.
• Do not consume more than the prescribed quantity.

• If allergic to this medicine inform the physician immediately.
• If find any other complication inform the physician immediately.
• Consult with the physician during pregnancy & lactation.
• Keep out of reach of children.